Sentences with phrase «pharma companies in»

Read more about the top medical device, biotech, and pharma companies in our

Similarly, biomedical and pharmaceutical research is bedazzled by molecular genetics, has sequenced the genome of one or two humans and a handful of other species and invested trillions on very rigidly reductionistic bottom - up research into medicines and diseases — with the result of empty drug pipelines for the big pharma companies in spite of all this investment.

Up to this point, Harack explains, start - up biotech companies in Canada have often looked to the U.S. and Europe, or to larger pharma companies in Canada, to recruit their staff.

But that's an approach that only one of the largest pharma companies in the world can take.

Rather than competing with the largest pharma companies in the world, she'd be competing with only a few academic groups.

Even mighty Novartis, the No. 2 pharma company in the world after Johnson & Johnson (JNJ), trimmed four divisions as it built up its cancer portfolio.

I; m a chemist for a small pharma company in the Baltimore area.

Sherina Petit Qualified: 2002 Made partner: 2012 Key cases: Representing the energy subsidiary of one of India's leading technology companies in an ICC arbitration worth $ 450m; acting for one of India's leading wind energy companies in an ICC arbitration; acting for an Indian pharma company in an LCIA arbitration.

SUMMARY * Currently working as a SAP WM, MM, LE: Fuctional Lead consultant in a roll - out Implementation project in a Pharma company in US.

Not exact matches

• BridgeBio Pharma, a Palo Alto, Calif. - based clinical - stage biopharmaceutical company, raised $ 135 million in funding.

In B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awrIn B.C. especially, companies such as QLT Inc., Angiotech Pharmaceuticals and Cardiome Pharma Corp. saw their valuations soar in the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awrin the early 2000s, only to come crashing to earth by the end of the decade as a result of competitive pressures, regulatory snags, strategic blunders and deals gone awry.

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

Kite Pharma, one of the companies chasing a new generation of cancer drugs called chimeric antigen receptor T - cell (CAR - T) therapies, announced a patient death in a clinical trial of its experimental KTE - C19.

Big biotech and pharma companies are absolutely dependent on being able to successfully innovate by partnering with and acquiring disruptive startups because of the nature of the patent cliff in pharmaceuticals.

The company runs clinical studies on behalf of its multinational pharma clients in oncology, respiratory / infectious disease and central nervous system disorders.

Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 % in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.

In periods of rising volatility, pharma companies are often especially vulnerable because of investors are paying big prices today for therapies expected to pay off over a long horizon.

«On Nasdaq, the main investors for biotech stocks are mainly U.S. funds, but, in Hong Kong, we can better tap Chinese and Asian investors as we are closer to them,» said Yang Dajun, chairman of Ascentage Pharma, a Chinese biotech company.

Trump appears to be simultaneously criticizing inversion mergers that shift drug companies» tax domiciles overseas, pharma's tactic of using manufacturing plants in European, Asian, and African countries, and high drug prices.

Valeant CEO Mike Pearson said in a conference call that Medicis will strengthen the company's place in medical dermatology and bring it to critical mass in aesthetics, a $ 12 - billion market that doesn't depend on government health - plan reimbursement and previously did not have a significant «big pharma» presence.

At an investment conference in May, Ackman explained that his long position in the pharma firm stemmed from his belief that Valeant's aggressive acquisition style — and the outsized returns it had so far produced — made the company akin to a younger version of Warren Buffett's Berkshire.

That's leaving entire areas open for the taking and Valeant — a specialty pharma company that focuses on dermatology, ophthalmology and over-the-counter medications — which already has a strong foothold in emerging markets is poised to fill that void.

The latest pharma innovation report from Deloitte holds some pretty grim news for pharma: returns on R&D investments by large cap companies slid to a mere 3.7 % in 2016, down from the 10.1 % returns seen in 2010 (although the cost of bringing a drug to market is beginning to stabilize).

Health Canada said that four companies have authorization to sell epinephrine auto - injectors — Kaleo Pharma, Taro Pharmaceutical Industries Ltd, Valeant Pharmaceuticals International Inc and Lincoln Medical Ltd — but none are currently marketing them in the country.

Say you're a pharma company with a key product which brings in about $ 1.49 billion in annual sales, or a little less than 10 % of your revenue stream.

In the process, French pharma giant Sanofi was eventually spurned despite a brief period when it seemed like the company was close to snagging a deal.

Ten of these companies, our honorees, have matched or outperformed the median annual revenue or profit for their peers in pharma, biotech, or tech, as tracked by EY and Capital IQ.

That deal cemented Actavis's rebirth as a branded and specialty pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&Pharma.»

Many of the recent Big Pharma deals and acquisition proposals have been motivated by the companies» desire to lower their tax rate by acquiring a foreign rival and moving their headquarters overseas in a process known as an inversion.

The companies jockeying for a first - to - market advantage in the space have encountered plenty of twists and turns along the way — and it appears that pharma giant Novartis may well achieve its original goal of a pioneering FDA approval for its own experimental treatment.

• Vicarius Pharma AG, a Switzerland - based which provides U.S. - based biopharmaceutical companies a new approach to commercializing assets in European markets, raised $ 21.8 million in funding.

The intense, full - day strategy sessions invariably ended with Cornelius getting a headache, he says — particularly when he sparred with executives in the company who clung to vestiges of big, fat pharma.

One day I came home from working at a big pharma company that had the same type of elevator as my condo building in Toronto.

At a moment when the world's fourth - largest pharmaceutical company by sales (Pfizer) is eagerly courting the world's ninth - largest (the very same AstraZeneca from which Bristol decoupled)-- offering, in late May, a monumental dowry of around $ 120 billion — one can be forgiven for not noticing the more substantive change that's sweeping the pharmaceutical industry: Big Pharma is getting smaller.

Jazz said in a filing that it did so in response to the overall takeover environment for pharma companies and in light of a patent litigation settlement that allows Hikma Pharmaceuticals to sell a generic version of Xyrem with Jazz receiving royalty payments on those sales.

Drug companies including Purdue Pharma LP and Johnson & Johnson have been fighting lawsuits by two California counties, the city of Chicago, four counties in New York and the state of Mississippi over their opioid marketing practices.

The largest donors to the various anti-weed political groups around the country include a billionaire casino tycoon, a woman who believes in reefer madness, a drug - crusading former U.S. ambassador, cops, prison guards, booze merchants, and a pharma company that sells the powerful painkiller fentanyl.

In 2017, according to Deloitte, the 12 largest bio - pharma companies got a mere 3.2 % return out of their drug - research arms.

In its first year of business, Sun Pharma generated more than $ 100,000 in sales, and in 1994 the company went public on the Bombay Stock ExchangIn its first year of business, Sun Pharma generated more than $ 100,000 in sales, and in 1994 the company went public on the Bombay Stock Exchangin sales, and in 1994 the company went public on the Bombay Stock Exchangin 1994 the company went public on the Bombay Stock Exchange.

A Reuters report citing sources who say that the firm is in talks with investment backs after being approached by several pharma companies for a buyout.

The five companies Ohio sued were Purdue Pharma LP, Johnson & Johnson's Janssen Pharmaceuticals Inc unit, a unit of Endo International Plc, Teva Pharmaceutical Industries Ltd's Cephalon unit and Allergan Plc, DeWine said during a press conference in Columbus livestreamed online.

While Tesaro is remaining publicly coy for now, a buyout has always been in the cards as big pharma companies continue to snap up biotechs that have already done drug development legwork for them.

We cover biopharma companies end - to - end — whether they're small, specialty drugmakers, generics companies or the biggest of Big Pharma — highlighting the accomplishments and acknowledging the defeats that all of them experience in the complicated, competitive pharmaceuticals industry.

In 2017, many pharma and medtech companies made acquisitions designed to leverage the target's R&D capabilities.

Similarly, innovation in collaborative, patient - centric drug development models that are being promoted by pharma companies, regulators and patient groups, have the ability to transform the industry and improve productivity significantly.

The company announced in September that Health Canada granted market authorization to formally transfer the Drug Identification Number (DIN) ownership of Belbuca (buprenorphine) buccal film in Canada to BDSI's commercial partner, Purdue Pharma in Canada.

The California Medical Association, which represents doctors in California, opposes the measure because of that claim, and also because the group said the cancellation of drug purchasing contracts the state already has with pharma companies «would remove many drugs from the Medi - Cal list of pre-approved medicines — creating a new prior authorization hurdle for patients and their physicians.»

Fortune Brainstorm Health, in association with IBM Watson Health, gathers not only C - suite leaders of top companies, hospitals, insurers, and cutting - edge pharma and biotech companies, but also titans of venture capital, tech and telecom, and other industries, all of who are rapidly changing the face of health care.

He also is a director and non-executive Chairman of Mayne Pharma Group Limited, an Australian specialty pharmaceutical company (which recently purchased Metrics, Inc., a pharmaceutical company in North Carolina), and a former member of the Prime Minister's Community Business Partnership.

US: Heather Bresch, the CEO of Mylan, an American pharmaceuticals company, finds herself at the center of one of the biggest pharma controversies in recent years: price - gouging.